Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/7884
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOliveira, Livia Costa de-
dc.contributor.authorNogueira Neto, José Firmino-
dc.contributor.authorGomes, Edney Gonçalves da Cunha-
dc.contributor.authorMachado, Letícia-
dc.date.accessioned2022-06-21T15:11:15Z-
dc.date.available2022-06-21T15:11:15Z-
dc.date.issued2019-
dc.identifier.citationOLIVEIRA, Livia Costa de et al. The erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic review. Transfusion Medicine, v. 29, p. 149-161, may 2019.-
dc.identifier.issn1365-3148-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/7884-
dc.descriptionp. 149-161.: il. p&b.-
dc.description.abstractTransfusion therapy is a common practice in the treatment of anaemia and can cause erythrocyte alloimmunisation. To systematise data related to erythrocyte alloimmunisation in patients with sickle cell disease (SCD), a bibliographic search was carried out in September 2017 to search for studies in four electronic databases. (i) Referring to the original work, (ii) being cohort or case–control, (iii) having been developed with individuals with SCD and (iv) having evaluated the erythrocyte alloimmunisation. Two reviewers identified the articles for inclusion in the study, extracted the predetermined data and carried out the evaluation of the methodological quality of the work. 21 studies were selected; the studies included data on 20 636 individuals (children and adults), were mostly published in the last 10 years, were developed in the United States and had high methodological quality. The occurrence of erythrocyte alloimmunisation ranged from 4·4 to 76%, and there was a higher rate of alloimmunisation against antigens of the Rh system. The risk factors for alloimmunisation were age; gender (female); red blood cell (RBC) units received; presence of ≥1 autoantibodies, TNF-𝛼, interleukin (IL1B), human leukocyte antigens (HLA)-DRB1 gene polymorphisms; first blood transfusion (BT) after 5 years of age, transfusion episodic, multiple or during inflammatory events, acute chest syndrome (ACS) and vase-occlusive crisis (VOC); increased percentage of CD41 T memory cells; and positive direct antiglobulin test. Transfusion policies should be developed to protect the patient and his or her health based on the main factors associated with its incidence.-
dc.publisherTransfusion Medicinept_BR
dc.subjectEritrócitos-
dc.subjectErythrocytes-
dc.subjectEritrocitos-
dc.subjectAnemia Falciforme-
dc.subjectAnemia, Sickle Cell-
dc.subjectAnemia de Células Falciformes-
dc.subjectAloimunização-
dc.titleThe erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic reviewpt_BR
dc.TypeArticlept_BR
Appears in Collections:Artigos de Periódicos da área de Nutrição

Files in This Item:
File Description SizeFormat 
The erythrocyte alloimmunisation in patients with sickle cell anaemia a systematic review.pdf287.96 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.